DM Clinical Research
DM Clinical Research is a privately held, Houston-based clinical trial site network operating 30+ research sites across 15 U.S. states, conducting Phase I-IV multi-therapeutic trials for pharmaceutical, biotechnology, and CRO sponsors while recruiting patients directly through its consumer portal and bilingual outreach.
- Company typePrivate
- Founded2006
- HeadquartersTomball, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What DM Clinical Research does
DM Clinical Research is a private, Houston-based clinical research site network founded in 2005 that conducts Phase I-IV clinical trials across a multi-therapeutic portfolio spanning vaccines, internal medicine, pediatrics, gastroenterology, psychiatry, neurology, and women's health. The company operates 30+ dedicated and affiliate research sites across 15 U.S. states supported by 700+ employees, including 180+ dedicated patient recruiters, GCP-trained physicians, bilingual clinicians, and centralized budget, contracts, regulatory, and study start-up teams. Site-level technical capabilities include CLIA-certified laboratories, PBMC processing for vaccine and immunology trials, ultra-low temperature storage (-70C freezers with dry ice and 24-hour temperature monitoring), and IATA-certified staff for biological materials handling. The company maintains a 320K+ physician and research contact database and 28M total patient access to support rapid, diverse enrollment.
The business generates revenue through professional services contracts with pharmaceutical, biotechnology, and CRO customers, earning per-study fees tied to enrollment milestones, site activation, and trial completion. Vaccine trials (255+ completed) represent a meaningful specialty revenue stream. DM Clinical serves two primary customer segments: B2B sponsors and CROs seeking high-enrollment, demographically diverse site networks, and B2C patient volunteers recruited via a consumer-facing portal (dmclinicaltrials.com), bilingual phone line (281-517-0550), community outreach campaigns (e.g., #HoustonFightsCOVID), and an Ambassador referral program that compensates participants for successful referrals. Sponsors are engaged directly through a business development team and industry events such as the World Vaccine Congress.
The company is independently and privately held with no disclosed venture capital, private equity, or parent ownership in the available data; no funding rounds or M&A activity are documented. Leadership includes CEO Mohammad Millwala, and the firm has been recognized with multiple industry awards including Best Clinical Trial Network (World Vaccine Congress, 2023), SCRS Excellence in Patient Centricity (2022), and Best Clinical Trial Site (World Vaccine Congress, 2021).
DM Clinical Research firmographics
Firmographics- Name
- DM Clinical Research
- Legal name
- DM Clinical
- Website
- https://dmclinicalresearch.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- DM Clinical Research is a privately held, Houston-based clinical trial site network operating 30+ research sites across 15 U.S. states, conducting Phase I-IV multi-therapeutic trials for pharmaceutical, biotechnology, and CRO sponsors while recruiting patients directly through its consumer portal and bilingual outreach.
- Ownership category
- akta.pro rank
DM Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where DM Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Tomball
- HQ country
- United States
- HQ region
- North America
Offices20 records
Markets served
DM Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Clinical Trial Conduct Services for Sponsors/CROs: DM Clinical earns fees from pharmaceutical and biotechnology companies for conducting Phase I-IV clinical trials at their site network. Revenue is generated per study contract based on enrollment milestones, site activation, and trial completion. The company also earns compensation per enrolled participant and for providing research infrastructure including facilities, staff, and regulatory support.
- Vaccine Trial Services: Specialized revenue stream from conducting vaccine trials (255+ completed), including influenza, COVID-19, RSV, HPV, and other infectious disease vaccines. Vaccine trials represent a significant portion of the company's trial portfolio.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Participant compensation for clinical trial participation |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
DM Clinical Research product offering
Product offeringCore offering
DM Clinical Research operates a network of 30+ dedicated and affiliate clinical trial investigator sites across the United States that conduct Phase I-IV clinical trials for pharmaceutical, biotechnology, and CRO sponsors across multiple therapeutic areas including vaccines, internal medicine, pediatrics, gastroenterology, psychiatry, neurology, and women's health. The company recruits patient participants through a consumer-facing portal and community outreach, and provides centralized budget, contracts, regulatory, and study start-up operations to support rapid trial activation and enrollment.
Product overview
DM Clinical Research is a multi-therapeutic clinical trial network that operates as a unified platform combining 30+ research sites across the United States. The core offering consists of Clinical Trial Network Services for conducting Phase I-IV studies, supported by a Patient Enrollment Platform (dmclinicaltrials.com) that connects patients with trials. Additional services include the Principal Investigator Partnership Program providing infrastructure access to physicians, and an Ambassador Referral Program for patient-driven recruitment. The company specializes in vaccines, internal medicine, pediatrics, gastroenterology, psychiatry, neurology, and women's health therapeutic areas.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Network Services
Quantifiable outcome
- 1,000+ clinical trials conducted with 18,056+ participants enrolled
- +3 more outcomes
Companies that use DM Clinical Research
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
DM Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DM Clinical Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Artisans of MedicineminorArtisans of Medicine is a Brooklyn, NY-based medical practice that operates as a DM Clinical partnership site, performing a variety of clinical studies in the New York market.
Scale indicators13 records
Recent moves7 records
Expansion highlights5 records
DM Clinical Research competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: Private, multi-therapeutic site network organization operating dedicated research sites across the U.S., directly comparable to DM Clinical in business model (SMO/site network), therapeutic breadth, and sponsor-facing services.
- Flourish Research: Multi-site clinical research organization with therapeutic breadth and dedicated patient-recruitment capabilities, competing in the same mid-market U.S. site-network category as DM Clinical.
- Centricity Research: Clinical research site network operating across the U.S. and Canada with integrated site operations, comparable to DM Clinical in offering Phase I-IV trials across multiple therapeutic areas to sponsors and CROs.
- Accel Research Sites: Multi-therapeutic clinical research site network conducting Phase I-IV trials for sponsors and CROs, with a similar diversified-therapeutics site-network model and patient-recruitment focus as DM Clinical.
- Benchmark Research: Private, multi-site clinical research organization operating across multiple U.S. regions with Phase I-IV trial capabilities and vaccine/infectious disease expertise, comparable to DM Clinical's service offering.
Broad incumbents
- IQVIA: Largest global CRO with extensive site network, technology platforms, and data assets. Overlaps with DM Clinical on multi-therapeutic trial conduct and patient recruitment at scale, but at significantly greater scope and resources.
- ICON plc: Global CRO formed through the PRA Health Sciences merger, with significant site-services and decentralized trial capabilities. A broad incumbent competing with DM Clinical for sponsor trial contracts across therapeutic areas.
- Syneos Health: Large, publicly traded CRO with site-management and patient-recruitment offerings. Broader and more global than DM Clinical but serves overlapping sponsors and CRO-side customers with comparable site-network services.
- Medpace Holdings: Mid-to-large CRO with embedded site operations and clinical trial management capabilities; broader portfolio than DM Clinical but overlaps in multi-therapeutic trial execution and sponsor-facing services.
Emerging players
- Clinipace Worldwide: Mid-sized, therapeutically focused CRO with site-management capabilities; partial overlap with DM Clinical in multi-therapeutic trial execution and sponsor-facing services, though more CRO-centric than pure site-network.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
DM Clinical Research social profiles
Digital presenceDM Clinical Research compliance and trust
Trust signalCompliance3 records
DM Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
DM Clinical Research leadership team
Management profileNumber of profiles
Profiles1 record
DM Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DM Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DM Clinical Research
What does DM Clinical Research do?
DM Clinical Research operates a network of 30+ dedicated and affiliate clinical trial investigator sites across the United States that conduct Phase I-IV clinical trials for pharmaceutical, biotechnology, and CRO sponsors across multiple therapeutic areas including vaccines, internal medicine, pediatrics, gastroenterology, psychiatry, neurology, and women's health. The company recruits patient participants through a consumer-facing portal and community outreach, and provides centralized budget, contracts, regulatory, and study start-up operations to support rapid trial activation and enrollment.
Is DM Clinical Research a public or private company?
DM Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DM Clinical Research founded?
DM Clinical Research was founded in 2006. It employs 501 to 1,000 people.
Where is DM Clinical Research based?
DM Clinical Research is headquartered in Tomball, United States, in the North America region.
How does DM Clinical Research make money?
Two revenue lines are on record. Clinical Trial Conduct Services for Sponsors/CROs are the primary driver. The others are vaccine Trial Services.
Who are DM Clinical Research's main competitors?
Direct peers on record are Velocity Clinical Research, Flourish Research, Centricity Research, Accel Research Sites and Benchmark Research. Broad incumbents are IQVIA, ICON plc, Syneos Health and Medpace Holdings. Clinipace Worldwide is listed as an emerging player.
Does DM Clinical Research have an API?
No public API is recorded for DM Clinical Research.
What industry is DM Clinical Research in?
DM Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 54171 and its SIC code is 8731.